User profiles for Frank W. Sellke
Frank Sellkebrown medical school Verified email at brown.edu Cited by 123617 |
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …
…, TS Metkus Jr, LC Nnacheta, SV Rao, FW Sellke… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, …
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, …
[HTML][HTML] Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
…, TA Libermann, JP Morgan, FW Sellke… - The Journal of …, 2003 - Am Soc Clin Investig
Preeclampsia, a syndrome affecting 5% of pregnancies, causes substantial maternal and fetal
morbidity and mortality. The pathophysiology of preeclampsia remains largely unknown. It …
morbidity and mortality. The pathophysiology of preeclampsia remains largely unknown. It …
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke …
…, R Lindquist, PM Nilsson, GC Roman, FW Sellke… - stroke, 2011 - Am Heart Assoc
Background and Purpose— This scientific statement provides an overview of the evidence
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …
Soluble endoglin contributes to the pathogenesis of preeclampsia
Preeclampsia is a pregnancy-specific hypertensive syndrome that causes substantial maternal
and fetal morbidity and mortality. Maternal endothelial dysfunction mediated by excess …
and fetal morbidity and mortality. Maternal endothelial dysfunction mediated by excess …
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association …
…, TS Metkus Jr, LC Nnacheta, SV Rao, FW Sellke… - Circulation, 2022 - Am Heart Assoc
Aim: The executive summary of the American College of Cardiology/American Heart
Association/Society for Cardiovascular Angiography and Interventions coronary artery …
Association/Society for Cardiovascular Angiography and Interventions coronary artery …
[HTML][HTML] Idarucizumab for dabigatran reversal
Background Specific reversal agents for non–vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
Post–cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication a consensus statement from the International liaison Committee on …
The contributors to this statement were selected to ensure expertise in all the disciplines
relevant to post–cardiac arrest care. In an attempt to make this document universally applicable …
relevant to post–cardiac arrest care. In an attempt to make this document universally applicable …
Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the International liaison Committee on …
AIM OF THE REVIEW: To review the epidemiology, pathophysiology, treatment and
prognostication in relation to the post-cardiac arrest syndrome. METHODS: Relevant articles were …
prognostication in relation to the post-cardiac arrest syndrome. METHODS: Relevant articles were …
[HTML][HTML] Idarucizumab for dabigatran reversal—full cohort analysis
Background Idarucizumab, a monoclonal antibody fragment, was developed to reverse the
anticoagulant effect of dabigatran. Methods We performed a multicenter, prospective, open-…
anticoagulant effect of dabigatran. Methods We performed a multicenter, prospective, open-…
Management of patients with peripheral artery disease (compilation of 2005 and 2011 accf/aha guideline recommendations) a report of the american college of …
This document is a compilation of the current American College of Cardiology Foundation/American
Heart Association (ACCF/AHA) practice guideline recommendations for peripheral …
Heart Association (ACCF/AHA) practice guideline recommendations for peripheral …